Chief Medical Officer
AyuVis Research Inc.
Fort Worth, Texas, United States
Novel Small Molecule Immunomodulator AVR-48 as an Adjuvant for Influenza Vaccine
Saturday, April 26, 2025
8:15am – 8:30am HST
Disclosure(s): I do not have any relevant financial / non-financial relationships with any proprietary interests.
